Showing results (451-460 of 491) with videos related to

Sort By:
Pageof 50
Science (New York, N.Y.)|October 12, 2023
Transcriptomic diversity of cell types across the adult human brainKimberly Siletti, Rebecca Hodge, Alejandro Mossi Albiach, et al.
Transfusion|January 21, 2021
A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disordersNabanita Bhunia, Rolla Abu-Arja, Joseph R Stanek, et al.
Autophagy|October 25, 2021
Muscle-generated BDNF (brain derived neurotrophic factor) maintains mitochondrial quality control in female micePalak Ahuja, Chun Fai Ng, Brian Pak Shing Pang, et al.
Annals of the Rheumatic Diseases|April 3, 2021
Effects of RANKL inhibition on promoting healing of bone erosion in rheumatoid arthritis using HR-pQCT: a 2-year, randomised, double-blind, placebo-controlled trialHo So, Isaac T Cheng, Sze-Lok Lau, et al.
Epidemics|November 5, 2021
Sustaining effective COVID-19 control in Malaysia through large-scale vaccinationPavithra Jayasundara, Kalaiarasu M Peariasamy, Kian Boon Law, et al.
Eclinicalmedicine|September 10, 2024
Conditional generative adversarial network-assisted system for radiation-free evaluation of scoliosis using a single smartphone photograph: a model development and validation studyZhong He, Neng Lu, Yi Chen, et al.
Cancer Research|November 18, 2008
Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugateGail D Lewis Phillips, Guangmin Li, Debra L Dugger, et al.
International Journal of Cardiology|July 26, 2015
Automated quantification of mitral valve anatomy using anatomical intelligence in three-dimensional echocardiographyChun-Na Jin, Ivan S Salgo, Robert J Schneider, et al.
European Heart Journal. Cardiovascular Imaging|July 12, 2024
Survival loss linked to guideline-based indications for degenerative mitral regurgitation surgeryDavid Vancraeynest, Anne-Catherine Pouleur, Christophe de Meester, et al.
Physics and Imaging in Radiation Oncology|May 13, 2026
Estimation of accumulated dose to organs at risk in head and neck cancer patients treated with scheduled replanning and dose painting in the ARTFORCE trialAnna Liza M P de Leeuw, Simon R van Kranen, Jordi Giralt, et al.
Pageof 50